Bourgeon Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-78,336
| Closed | -$6.57M | – | 122 |
|
|
2024
Q3 | $6.57M | Buy |
78,336
+218
| +0.3% | +$16.6K | 1.26% | 33 |
|
|
2024
Q2 | $5.36M | Sell |
78,118
-94
| -0.1% | -$6.27K | 1.05% | 35 |
|
|
2024
Q1 | $5.73M | Buy |
78,212
+1,459
| +2% | +$112K | 1.12% | 36 |
|
|
2023
Q4 | $6.22M | Sell |
76,753
-71,313
| -48% | -$5.55M | 1.37% | 32 |
|
|
2023
Q3 | $11.1M | Sell |
148,066
-291
| -0.2% | -$22.4K | 2.6% | 9 |
|
|
2023
Q2 | $11.4M | Sell |
148,357
-747
| -0.5% | -$59.6K | 2.67% | 9 |
|
|
2023
Q1 | $12.4M | Sell |
149,104
-1,050
| -0.7% | -$87K | 2.95% | 9 |
|
|
2022
Q4 | $12.9M | Sell |
150,154
-25,374
| -14% | -$2.01M | 3.16% | 6 |
|
|
2022
Q3 | $10.8M | Buy |
175,528
+2,685
| +2% | +$169K | 2.98% | 9 |
|
|
2022
Q2 | $10.7M | Buy |
172,843
+2,719
| +2% | +$168K | 2.83% | 10 |
|
|
2022
Q1 | $10.1M | Buy |
170,124
+5,190
| +3% | +$332K | 2.29% | 23 |
|
|
2021
Q4 | $12M | Buy |
164,934
+1,560
| +1% | +$107K | 2.47% | 14 |
|
|
2021
Q3 | $11.4M | Sell |
163,374
-28
| -0% | -$1.97K | 2.44% | 16 |
|
|
2021
Q2 | $11.3M | Buy |
163,402
+3,337
| +2% | +$223K | 2.42% | 17 |
|
|
2021
Q1 | $10.3M | Buy |
160,065
+57,222
| +56% | +$3.69M | 2.29% | 17 |
|
|
2020
Q4 | $5.99M | Sell |
102,843
-39,774
| -28% | -$2.4M | 1.48% | 29 |
|
|
2020
Q3 | $9.01M | Buy |
142,617
+60,211
| +73% | +$4.18M | 2.73% | 11 |
|
|
2020
Q2 | $6.34M | Buy |
82,406
+21,830
| +36% | +$1.67M | 2.25% | 19 |
|
|
2020
Q1 | $4.53M | Buy |
60,576
+56,726
| +1,473% | +$3.92M | 2.35% | 16 |
|
|
2019
Q4 | $250K | Sell |
3,850
-200
| -5% | -$13K | 0.12% | 63 |
|
|
2019
Q3 | $257K | Buy |
4,050
+700
| +21% | +$45.8K | 0.14% | 60 |
|
|
2019
Q2 | $226K | Hold |
3,350
| – | – | 0.13% | 63 |
|
|
2019
Q1 | $218K | Buy |
+3,350
| New | +$223K | 0.13% | 62 |
|
|
2017
Q3 | – | Sell |
-3,250
| Closed | -$230K | – | 91 |
|
|
2017
Q2 | $230K | Buy |
+3,250
| New | +$216K | 0.14% | 67 |
|
|
2016
Q4 | – | Sell |
-7,550
| Closed | -$597K | – | 96 |
|
|
2016
Q3 | $597K | Buy |
7,550
+650
| +9% | +$52.8K | 0.38% | 55 |
|
|
2016
Q2 | $576K | Buy |
6,900
+4,400
| +176% | +$390K | 0.37% | 54 |
|
|
2016
Q1 | $230K | Hold |
2,500
| – | – | 0.15% | 78 |
|
|
2015
Q4 | $253K | Hold |
2,500
| – | – | 0.16% | 75 |
|
|
2015
Q3 | $245K | Hold |
2,500
| – | – | 0.17% | 83 |
|
|
2015
Q2 | $293K | Hold |
2,500
| – | – | 0.18% | 89 |
|
|
2015
Q1 | $245K | Hold |
2,500
| – | – | 0.15% | 95 |
|
|
2014
Q4 | $236K | Hold |
2,500
| – | – | 0.14% | 93 |
|
|
2014
Q3 | $266K | Hold |
2,500
| – | – | 0.16% | 90 |
|
|
2014
Q2 | $207K | Buy |
+2,500
| New | +$195K | 0.11% | 107 |
|
Other funds holding GILD
Bourgeon Capital Management's GILD Position: Q4 2024 in Review
Bourgeon Capital Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 78,336 shares — an estimated $6.57M sold.
Bourgeon Capital Management first reported a position in GILD in Q2 2014 and held it in 34 quarters. The position peaked at $12.9M in Q4 2022. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Bourgeon Capital Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
- Bourgeon Capital Management sold 78,336 Gilead Sciences shares in Q4 2024, an estimated $6.57M.
- Bourgeon Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 34 quarters.
- Bourgeon Capital Management's Gilead Sciences position peaked at $12.9M in Q4 2022.
- 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Bourgeon Capital Management's 13F filing for Q4 2024, filed 17 Jan 2025.